{
  "retracted": false,
  "timestamp": 1469404800000,
  "updates": [
    {
      "timestamp": 1585202943562,
      "identifier": {
        "doi": "10.1186/s12885-016-2559-8"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1186/s12885-016-2440-9"
  },
  "publisher": "Springer Science and Business Media LLC",
  "title": "Erratum to: Survival, safety, and prognostic factors for outcome with Regorafenib in patients with metastatic colorectal cancer refractory to standard therapies: results from a multicenter study (REBECCA) nested within a compassionate use program"
}
